Shinsuke Fujii
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shinsuke Fujii has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
Tamotsu Kiyoshima
Laboratory of Oral Pathology, Division of Maxillofacial Diagnostic and Surgical sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan
14 shared publicationsKana Hasegawa
Laboratory of Oral Pathology, Division of Maxillofacial Diagnostic and Surgical sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan
10 shared publicationsYudai Tajiri
Laboratory of Oral Pathology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan; Department of Dentistry and Oral Surgery, National Hospital Organization, Fukuokahigashi Medical Center, 1-1-1 Chidori, Koga, Fukuoka, 811-3195, Japan
7 shared publicationsRyoko Nagano
Laboratory of Oral Pathology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science Kyushu University Fukuoka Japan
6 shared publicationsKari J. Kurppa
Institute of Biomedicine and MediCity Research Laboratories, University of Turku, Turku, Finland
5 shared publicationsShinji Matsumoto
Department of Oral Physiology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
5 shared publications
Latest Publications
- Open Access
- 12 October 2026
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
ARL4C in oral cancer cells promotes stromal RANKL expression via a RelA-dependent inflammatory axis in stromal fibroblasts
Purpose: Jawbone destruction in oral squamous cell carcinoma (OSCC) is driven by receptor activator of nuclear factor-κB (NF-κB) ligand (RANKL)-mediated osteoclastogenesis. Although the cellular sources of RANKL and its regulatory mechanisms within the OSCC microenvironment remain elusive, this study aimed to elucidate how ADP-ribosylation factor-like 4 C (ARL4C), a key oncogene in oral cancer, promotes the pro-osteoclastogenic microenvironment by identifying the specific signaling axis responsible for RANKL induction in stromal fibroblasts. Methods: Stromal cells were cultured with OSCC-conditioned medium (CM), followed by comprehensive RNA sequencing and pathway enrichment analysis. Identified signaling pathways were validated using siRNA and pharmacological inhibitors. Spatial localization in human clinical specimens was evaluated by immunohistochemistry. Results: Transcriptomic profiling revealed significant enrichment of the NF-κB and Stat3 pathways in stromal cells exposed to OSCC-CM. Inhibition of RelA subunit (a major subunit of NF-κB) significantly reduced tumor-induced RANKL expression. We found that ARL4C expression in cancer cells promoted the secretion of proinflammatory cytokines, establishing a sustained RelA-mediated inflammatory response in stromal fibroblasts. Immunohistochemical analysis of human OSCC specimens confirmed that phosphorylated RelA and RANKL were co-expressed in α-SMA-positive stromal fibroblasts at the bone-invasive front, even in areas distant from tumor nests. Conclusions: This study identifies a tumor–stromal signaling axis where ARL4C in OSCC cells triggers a RelA-mediated inflammatory response in stromal fibroblasts. These fibroblasts act as a critical, non-canonical RANKL source driving jawbone destruction. Targeting the ARL4C–RelA axis might represent a promising therapeutic strategy for suppressing stromal RANKL expression and improving quality of life for OSCC patients.
- 12 October 2026
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
Open AccessARL4C in oral cancer cells promotes stromal RANKL expression via a RelA-dependent inflammatory axis in stromal fibroblasts
Purpose: Jawbone destruction in oral squamous cell carcinoma (OSCC) is driven by receptor activator of nuclear factor-κB (NF-κB) ligand (RANKL)-mediated osteoclastogenesis. Although the cellular sources of RANKL and its regulatory mechanisms within the OSCC microenvironment remain elusive, this study aimed to elucidate how ADP-ribosylation factor-like 4 C (ARL4C), a key oncogene in oral cancer, promotes the pro-osteoclastogenic microenvironment by identifying the specific signaling axis responsible for RANKL induction in stromal fibroblasts. Methods: Stromal cells were cultured with OSCC-conditioned medium (CM), followed by comprehensive RNA sequencing and pathway enrichment analysis. Identified signaling pathways were validated using siRNA and pharmacological inhibitors. Spatial localization in human clinical specimens was evaluated by immunohistochemistry. Results: Transcriptomic profiling revealed significant enrichment of the NF-κB and Stat3 pathways in stromal cells exposed to OSCC-CM. Inhibition of RelA subunit (a major subunit of NF-κB) significantly reduced tumor-induced RANKL expression. We found that ARL4C expression in cancer cells promoted the secretion of proinflammatory cytokines, establishing a sustained RelA-mediated inflammatory response in stromal fibroblasts. Immunohistochemical analysis of human OSCC specimens confirmed that phosphorylated RelA and RANKL were co-expressed in α-SMA-positive stromal fibroblasts at the bone-invasive front, even in areas distant from tumor nests. Conclusions: This study identifies a tumor–stromal signaling axis where ARL4C in OSCC cells triggers a RelA-mediated inflammatory response in stromal fibroblasts. These fibroblasts act as a critical, non-canonical RANKL source driving jawbone destruction. Targeting the ARL4C–RelA axis might represent a promising therapeutic strategy for suppressing stromal RANKL expression and improving quality of life for OSCC patients.
- 19 August 2025
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 67 (4) , 100691
Complement components C1r and C1s promote oral squamous cell carcinoma cell proliferation
- 19 August 2025
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 67 (4) , 100691
Complement components C1r and C1s promote oral squamous cell carcinoma cell proliferation
- Open Access
- 20 June 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (25) , e42936
An ancient schwannoma with venous malformation-like features of the tongue: A case report and review of the literature
Rationale: Composite lesions of neurogenic tumors with vascular malformations, which were once included among hemangiomas, are extremely rare and can be classified into 2 types: conjoined and discrete associations, with the former representing a single lesion of vascular malformation within tumor tissue. To date, we have found 24 composite lesions (conjoined association type) of schwannomas coexisting with vascular malformations. However, such composite lesions should be interpreted with caution. Patient concerns: A 29-year-old woman had recognized swelling of the tongue 5 years prior to her initial hospital visit and the lesion had recently been slowly growing. Diagnoses: Based on clinical examinations, including imaging studies, the tumorous lesion was clinically diagnosed as a schwannoma, but a benign salivary gland tumor and venous malformation (VM) were not completely ruled out. Interventions: The lesion was excised with safety margin. Outcomes: The excised sample revealed 2 intriguing features; however, the lesion was diagnosed as an ancient schwannoma with VM-like features because of the lack of definitive findings that would make these lesions a composite of independent lesions. There was no evidence of recurrence or distant metastasis at the 16-month follow-up after excision. Lessons: Ancient schwannomas of the oral cavity are rare. In particular, schwannomas that appear as composite lesions of schwannomas with vascular malformations are extremely rare. Here, we report the first case of an ancient schwannoma with VM-like features of the tongue. It is important for clinicians to accumulate information on these rare cases to make an accurate preoperative diagnosis and to plan appropriate treatment.
- 20 June 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (25) , e42936
Open AccessAn ancient schwannoma with venous malformation-like features of the tongue: A case report and review of the literature
Rationale: Composite lesions of neurogenic tumors with vascular malformations, which were once included among hemangiomas, are extremely rare and can be classified into 2 types: conjoined and discrete associations, with the former representing a single lesion of vascular malformation within tumor tissue. To date, we have found 24 composite lesions (conjoined association type) of schwannomas coexisting with vascular malformations. However, such composite lesions should be interpreted with caution. Patient concerns: A 29-year-old woman had recognized swelling of the tongue 5 years prior to her initial hospital visit and the lesion had recently been slowly growing. Diagnoses: Based on clinical examinations, including imaging studies, the tumorous lesion was clinically diagnosed as a schwannoma, but a benign salivary gland tumor and venous malformation (VM) were not completely ruled out. Interventions: The lesion was excised with safety margin. Outcomes: The excised sample revealed 2 intriguing features; however, the lesion was diagnosed as an ancient schwannoma with VM-like features because of the lack of definitive findings that would make these lesions a composite of independent lesions. There was no evidence of recurrence or distant metastasis at the 16-month follow-up after excision. Lessons: Ancient schwannomas of the oral cavity are rare. In particular, schwannomas that appear as composite lesions of schwannomas with vascular malformations are extremely rare. Here, we report the first case of an ancient schwannoma with VM-like features of the tongue. It is important for clinicians to accumulate information on these rare cases to make an accurate preoperative diagnosis and to plan appropriate treatment.
- Open Access
- 7 January 2025
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
- Vol. 37 (4) , 839-848
Oral metastatic tumor (renal cell carcinoma) in maxillary gingiva: A case report and systematic review
- 7 January 2025
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
- Vol. 37 (4) , 839-848
Open AccessOral metastatic tumor (renal cell carcinoma) in maxillary gingiva: A case report and systematic review
- Open Access
- 20 June 2024
- Published by Elsevier in Pathology - Research and Practice
- Vol. 260, 155420
Wnt/β-catenin-YAP axis in the pathogenesis of primary intraosseous carcinoma NOS, deriving from odontogenic keratocyst
- 20 June 2024
- Published by Elsevier in Pathology - Research and Practice
- Vol. 260, 155420
Open AccessWnt/β-catenin-YAP axis in the pathogenesis of primary intraosseous carcinoma NOS, deriving from odontogenic keratocyst
- 20 January 2024
- Published by Elsevier in Pathology - Research and Practice
- Vol. 254, 155148
Wnt/β-catenin-C-kit axis may play a role in adenoid cystic carcinoma prognostication
- 20 January 2024
- Published by Elsevier in Pathology - Research and Practice
- Vol. 254, 155148
Wnt/β-catenin-C-kit axis may play a role in adenoid cystic carcinoma prognostication
- 10 January 2024
- Published by Wiley in International Endodontic Journal
- Vol. 57 (3) , 344-354
The IL‐1β‐p65 axis stimulates quiescent odontogenic epithelial cell rests via TGF‐β signalling to promote cell proliferation of the lining epithelia in radicular cysts: A laboratory investigation
Aim: Cyst formation of the jaws is frequently accompanied by the proliferation of odontogenic epithelial cells located in the periodontal ligament (PDL), which consists of heterozygous cells and includes the most fibroblasts. The lining epithelium of radicular cyst, an odontogenic cyst of inflammatory origin, is derived from the proliferation of the remnants of the Hertwig epithelial root sheath (odontogenic epithelial cell rests of Malassez; ERMs) in the PDL. ERMs are maintained at a lower proliferative state under physiological conditions, but the regulatory mechanisms underlying the inflammation‐dependent enhanced‐proliferative capabilities of ERMs are not fully understood. The aim of this study was to evaluate the effects of cytokine pathway association between TGF‐β signalling and IL‐1β signalling on the regulation of odontogenic epithelial cell proliferation using radicular cyst pathological specimens and odontogenic epithelial cell lines.Methodology: Immunofluorescence analyses were performed to clarify the expression levels of Smad2/3 and Ki‐67 in ERMs of 8‐week‐old mouse molar specimens. In radicular cyst (n = 52) and dentigerous cysts (n = 6) specimens from human patients, the expression of p65 (a main subunit of NF‐κB), Smad2/3 and Ki‐67 were investigated using immunohistochemical analyses. Odontogenic epithelial cells and PDL fibroblastic cells were co‐cultured with or without an inhibitor or siRNAs. Odontogenic epithelial cells were cultured with or without TGF‐β1 and IL‐1β. The proliferative capabilities and Smad2 phosphorylation levels of odontogenic epithelial cells were examined.Results: Immunohistochemically, Smad2/3‐positivity was increased, and p65‐positivity and Ki‐67‐positivity were decreased both in ERMs and in the epithelial cells in dentigerous cysts, a non‐inflammatory developmental cyst. In contrast, p65‐positive cells, along with the expression of Ki‐67, were increased and Smad2/3‐positive cells were decreased in the lining epithelia of radicular cysts. Co‐culture experiments with odontogenic epithelial cells and PDL fibroblastic cells revealed that PDL cells‐derived TGF‐β1/2 and their downstream signalling suppressed odontogenic epithelial cell proliferation. Moreover, TGF‐β1 stimulation induced Smad2 phosphorylation and suppressed odontogenic epithelial cell proliferation, while IL‐1β stimulation reversed these phenotypes through p65 transactivation.Conclusions: These results suggest that IL‐1β‐p65 signalling promotes odontogenic epithelial cell proliferation through suppressing TGF‐β‐Smad2 signalling, which would be involved in the pathogenesis of radicular cysts.
- 10 January 2024
- Published by Wiley in International Endodontic Journal
- Vol. 57 (3) , 344-354
The IL‐1β‐p65 axis stimulates quiescent odontogenic epithelial cell rests via TGF‐β signalling to promote cell proliferation of the lining epithelia in radicular cysts: A laboratory investigation
Aim: Cyst formation of the jaws is frequently accompanied by the proliferation of odontogenic epithelial cells located in the periodontal ligament (PDL), which consists of heterozygous cells and includes the most fibroblasts. The lining epithelium of radicular cyst, an odontogenic cyst of inflammatory origin, is derived from the proliferation of the remnants of the Hertwig epithelial root sheath (odontogenic epithelial cell rests of Malassez; ERMs) in the PDL. ERMs are maintained at a lower proliferative state under physiological conditions, but the regulatory mechanisms underlying the inflammation‐dependent enhanced‐proliferative capabilities of ERMs are not fully understood. The aim of this study was to evaluate the effects of cytokine pathway association between TGF‐β signalling and IL‐1β signalling on the regulation of odontogenic epithelial cell proliferation using radicular cyst pathological specimens and odontogenic epithelial cell lines.Methodology: Immunofluorescence analyses were performed to clarify the expression levels of Smad2/3 and Ki‐67 in ERMs of 8‐week‐old mouse molar specimens. In radicular cyst (n = 52) and dentigerous cysts (n = 6) specimens from human patients, the expression of p65 (a main subunit of NF‐κB), Smad2/3 and Ki‐67 were investigated using immunohistochemical analyses. Odontogenic epithelial cells and PDL fibroblastic cells were co‐cultured with or without an inhibitor or siRNAs. Odontogenic epithelial cells were cultured with or without TGF‐β1 and IL‐1β. The proliferative capabilities and Smad2 phosphorylation levels of odontogenic epithelial cells were examined.Results: Immunohistochemically, Smad2/3‐positivity was increased, and p65‐positivity and Ki‐67‐positivity were decreased both in ERMs and in the epithelial cells in dentigerous cysts, a non‐inflammatory developmental cyst. In contrast, p65‐positive cells, along with the expression of Ki‐67, were increased and Smad2/3‐positive cells were decreased in the lining epithelia of radicular cysts. Co‐culture experiments with odontogenic epithelial cells and PDL fibroblastic cells revealed that PDL cells‐derived TGF‐β1/2 and their downstream signalling suppressed odontogenic epithelial cell proliferation. Moreover, TGF‐β1 stimulation induced Smad2 phosphorylation and suppressed odontogenic epithelial cell proliferation, while IL‐1β stimulation reversed these phenotypes through p65 transactivation.Conclusions: These results suggest that IL‐1β‐p65 signalling promotes odontogenic epithelial cell proliferation through suppressing TGF‐β‐Smad2 signalling, which would be involved in the pathogenesis of radicular cysts.
- 7 September 2023
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 679, 167-174
Arl4c is involved in tooth germ development through osteoblastic/ameloblastic differentiation
- 7 September 2023
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 679, 167-174
Arl4c is involved in tooth germ development through osteoblastic/ameloblastic differentiation
- 26 April 2023
- Published by Wiley in Pathology International
- Vol. 73 (6) , 217-233
The role of Wnt, ARL4C, and Sema3A in developmental process and disease pathogenesis
Various types of tumors, including malignant and benign ones, occur in the oral cavity. These arise from the mucosal epithelium, odontogenic epithelium, and salivary gland. To date, few major driver events in oral tumors have been identified. Accordingly, molecular targets in anti‐tumor therapy for oral tumors are lacking. We focused on elucidating the function of aberrantly activated signal transduction related to oral tumor formation, especially in oral squamous cell carcinoma, ameloblastoma, and adenoid cystic carcinoma, which are raised as common oral tumors. Wnt/β‐catenin‐dependent pathway is involved in the developmental process, organ homeostasis and disease pathogenesis through regulating various cellular functions by enhancing transcriptional activity. Recently, we identified ADP‐ribosylation factor (ARF)‐like 4c (ARL4C) and Semaphorin 3A (Sema3A), the expression of which is regulated by Wnt/β‐catenin‐dependent pathway, and characterized their functions in the developmental process and tumor formation. This review highlights the recent advances in understanding the roles of Wnt/β‐catenin‐dependent pathway, ARL4C and Sema3A, as determined by pathological and experimental studies.
- 26 April 2023
- Published by Wiley in Pathology International
- Vol. 73 (6) , 217-233
The role of Wnt, ARL4C, and Sema3A in developmental process and disease pathogenesis
Various types of tumors, including malignant and benign ones, occur in the oral cavity. These arise from the mucosal epithelium, odontogenic epithelium, and salivary gland. To date, few major driver events in oral tumors have been identified. Accordingly, molecular targets in anti‐tumor therapy for oral tumors are lacking. We focused on elucidating the function of aberrantly activated signal transduction related to oral tumor formation, especially in oral squamous cell carcinoma, ameloblastoma, and adenoid cystic carcinoma, which are raised as common oral tumors. Wnt/β‐catenin‐dependent pathway is involved in the developmental process, organ homeostasis and disease pathogenesis through regulating various cellular functions by enhancing transcriptional activity. Recently, we identified ADP‐ribosylation factor (ARF)‐like 4c (ARL4C) and Semaphorin 3A (Sema3A), the expression of which is regulated by Wnt/β‐catenin‐dependent pathway, and characterized their functions in the developmental process and tumor formation. This review highlights the recent advances in understanding the roles of Wnt/β‐catenin‐dependent pathway, ARL4C and Sema3A, as determined by pathological and experimental studies.
- 26 April 2023
- Published by Elsevier in Pathology - Research and Practice
- Vol. 246, 154493
Stepwise activation of p63 and the MEK/ERK pathway induces the expression of ARL4C to promote oral squamous cell carcinoma cell proliferation
- 26 April 2023
- Published by Elsevier in Pathology - Research and Practice
- Vol. 246, 154493
Stepwise activation of p63 and the MEK/ERK pathway induces the expression of ARL4C to promote oral squamous cell carcinoma cell proliferation